Eyal Flom
Director/Board Member bei INNOCAN PHARMA CORPORATION
Vermögen: 534 437 $ am 31.03.2024
Profil
Eyal Flom is currently the Director at Revium Recovery, Inc. He is also the Secretary & Director at InnoCan Pharma Corp.
and the Director at NurExone Biologic Ltd.
In the past, he served as the Legal Counsel at the Israeli Pharmaceutical Association.
Mr. Flom's former job includes being the Director at NurExone Biologic, Inc. Mr. Flom holds an MBA from the University of Derby and a graduate degree from Tel-Aviv University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.03.2024 | 2 375 277 ( 0,89% ) | 534 437 $ | 31.03.2024 |
Aktive Positionen von Eyal Flom
| Unternehmen | Position | Beginn |
|---|---|---|
| INNOCAN PHARMA CORPORATION | Director/Board Member | 25.09.2019 |
| REVIUM RECOVERY INC. | Director/Board Member | - |
| Israeli Pharmaceutical Association | General Counsel | 01.04.1995 |
NurExone Biologic Ltd.
 NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The private company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022. | Director/Board Member | - |
Ehemalige bekannte Positionen von Eyal Flom
| Unternehmen | Position | Ende |
|---|---|---|
| NUREXONE BIOLOGIC INC. | Director/Board Member | 08.05.2023 |
Ausbildung von Eyal Flom
| University of Derby | Masters Business Admin |
| Tel-Aviv University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| REVIUM RECOVERY INC. | Distribution Services |
| INNOCAN PHARMA CORPORATION | Health Technology |
| NUREXONE BIOLOGIC INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Israeli Pharmaceutical Association | |
NurExone Biologic Ltd.
NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The private company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022. | Health Technology |
